TBP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.961400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.986380E-01
Normal-vs-Stage2
8.564000E-03
Normal-vs-Stage3
8.253600E-02
Normal-vs-Stage4
3.089200E-01
Stage1-vs-Stage2
7.604200E-01
Stage1-vs-Stage3
2.651200E-01
Stage1-vs-Stage4
7.848800E-01
Stage2-vs-Stage3
1.634580E-01
Stage2-vs-Stage4
5.110200E-01
Stage3-vs-Stage4
1.605020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.117700E-03
Normal-vs-AfricanAmerican
3.960800E-01
Normal-vs-Asian
3.761700E-02
Caucasian-vs-AfricanAmerican
4.090400E-01
Caucasian-vs-Asian
4.004200E-01
AfricanAmerican-vs-Asian
2.043000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.222900E-03
Normal-vs-Female
1.612310E-02
Male-vs-Female
2.806800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.657400E-01
Normal-vs-Age(41-60Yrs)
3.381400E-01
Normal-vs-Age(61-80Yrs)
1.015520E-02
Normal-vs-Age(81-100Yrs)
8.614200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.865600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.428600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.975000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.441900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.830600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.871800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.955700E-02
Normal-vs-Daily Drinker
2.279000E-01
Normal-vs-Weekly Drinker
2.650200E-02
Normal-vs-Occasional Drinker
3.347600E-02
Normal-vs-Social Drinker
3.071600E-01
Non Drinker-vs-Daily Drinker
4.815200E-01
Non Drinker-vs-Weekly Drinker
8.661400E-01
Non Drinker-vs-Occasional Drinker
6.489800E-01
Non Drinker-vs-Social Drinker
4.965400E-01
Daily Drinker-vs-Weekly Drinker
6.329400E-01
Daily Drinker-vs-Occasional Drinker
2.234800E-01
Daily Drinker-vs-Social Drinker
1.501770E-01
Weekly Drinker-vs-Occasional Drinker
5.383200E-01
Weekly Drinker-vs-Social Drinker
4.170200E-01
Occasional Drinker-vs-Social Drinker
8.869400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.256400E-02
Normal-vs-Grade 2
4.903700E-03
Normal-vs-Grade 3
9.998900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.115600E-01
Grade 1-vs-Grade 3
8.284000E-01
Grade 1-vs-Grade 4
4.256400E-02
Grade 2-vs-Grade 3
3.796400E-01
Grade 2-vs-Grade 4
4.903700E-03
Grade 3-vs-Grade 4
9.998900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.123800E-03
Normal-vs-NonDiabetic
2.848400E-01
Diabetic-vs-NonDiabetic
1.719370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.728600E-01
Normal-vs-NoPancreatitis
2.722400E-01
Pancreatitis-vs-NoPancreatitis
9.195400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.884100E-02
Normal-vs-N1
2.897400E-01
N0-vs-N1
4.832600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.585600E-01
Normal-vs-TP53-NonMutant
6.202300E-02
TP53-Mutant-vs-TP53-NonMutant
1.626020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
